Qiang Wang, PhD

Qiang Wang, PhD





Qiang Wang, PhD

The research of Qiang Wang, PhD, focuses on the molecular mechanism of cancer progression and metastasis, the signaling network involved in pancreatic tissue regeneration and pathogenesis of pancreatitis and pancreatic cancer, and cancer-stromal cell interaction and its role in tumorigenesis.

  • Master's: Fordham University, 1994
  • Doctorate: University of Pennsylvania School of Medicine, 1998
  • UCLA Clinical and Translational Science Institute (CTSI) Center for Translational Technologies(CTT) Core Voucher Award, 2015
  • Cedars-Sinai/Sanford-Burnham Joint Research Grant Award, 2011
  • Donna and Jesse Garber Award for Cancer Research, 2010

Click here for a list of peer-reviewed publications.

  • Morvaridi S, Dhall D, Greene MI, Pandol SJ, Wang Q. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci Rep. 2015 Nov 16;5:16759.
  • Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene. 2013;32(17):2220-2229.
  • Berezov A, Freudenberg JA, Cai Z, Zhang H, Thompson T, Murali R, Greene MI, Wang Q.Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin. Oncogene. 2012;31(15):1938-1948.


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.